SEC Form 4 · accession 0001104659-16-095143
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Howard Liang
Officer — CFO & Chief Strategy Officer
Period of report
Feb 8, 2016
Accepted (ET)
Feb 9, 2016 · 8:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2,F3 | Feb 8, 2016 | P | 65,000 | $1.85 | A | 65,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These ordinary shares are in the form of American Depositary Shares ("ADSs"). Each ADS represents 13 ordinary shares of the Issuer.
- F2These ordinary shares in the form of the ADSs were purchased through a directed share program in connection with the initial public offering of the Issuer.
- F3Calculated based on the initial public offering price of $24.00 per ADS divided by 13, the then ordinary share-to-ADS ratio.